Dana Lambert

Dr. Dana Lambert is an entrepreneur with expertise in pharmaceutical development. She received her Ph.D. from the Faculty of Pharmaceutical Sciences at the University of British Columbia (UBC) with a focus on cannabinoid pharmacology. Dr. Lambert played a role in anti-infective cannabinoid research, resulting in several pharmaceutical composition patents filed by the University of British Columbia. She successfully negotiated exclusive licensing rights to the technologies for commercial development under Andira’s Infectious Disease Program. Dr. Lambert is also a licensed pharmacist (RPh) and previously served as a healthcare executive for the Vancouver Island Health Authority, managing clinical research programs and quality & safety initiatives.